David Fisher, Executive Chairman of Enova International, Inc. (NYSE:ENVA), filed a Form 4 on August 27, 2026, disclosing the exercise of stock options and the subsequent sale of common shares on August 25 and August 26, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Key Highlights
- August 25 option exercise: Fisher exercised Non-Qualified Stock Options to acquire 9,491 shares of common stock at an exercise price of $20.73 per share.
- August 25 sale: Fisher sold 9,491 shares at a weighted average price of $244.0104, with individual trade prices ranging from $241.46 to $251.20.
- August 26 option exercise: Fisher exercised an additional 9,078 shares at the same exercise price of $20.73 per share.
- August 26 sale: Fisher sold 9,078 shares at a weighted average price of $239.1631, with individual trade prices ranging from $236.29 to $244.93.
- Post-transaction holdings: Following all reported transactions, Fisher directly held 306,444 shares of Enova common stock.
- Trading plan: Both sales were effected pursuant to a Rule 10b5-1 trading plan adopted on January 30, 2026.
- Remaining derivative securities: Fisher held 166,113 Non-Qualified Stock Options with limited SARs directly following the August 26 transactions.
Fisher's Option Exercises and Sales at Enova International
According to the filing, David Fisher serves as Executive Chairman and Director of Enova International, Inc., an issuer whose common stock carries a par value of $0.00001 per share. The reported transactions on August 25 and August 26, 2026, each followed the same pattern: Fisher exercised Non-Qualified Stock Options to acquire shares, then disposed of the same number of shares on the open market the same day. The exercise price for both sets of options was $20.73 per share, as reported in Table II of the filing.
On August 25, 2026, Fisher's directly held share count rose to 315,935 following the exercise of 9,491 options, and then fell to 306,444 after the sale of those 9,491 shares. On August 26, 2026, the direct holdings increased again to 315,522 following the exercise of 9,078 options, and returned to 306,444 after the sale of 9,078 shares, according to the filing's Table I disclosures.
The filing notes that the Non-Qualified Stock Options were granted in tandem with limited stock appreciation rights (SARs). As disclosed in the explanatory footnotes, the SAR may only be exercised during a window following a "Change in Control" of the issuer, and any payment is contingent on an "Offer" being made as defined in the grant agreement. The options underlying these transactions vested in substantially equal one-third increments on February 11, 2021, February 11, 2022, and February 11, 2023, and carry an expiration date of February 11, 2027, per the filing. Following the August 26 transactions, Fisher held 166,113 derivative securities directly.
What Was Disclosed
Enova International Executive Chairman David Fisher disclosed the exercise of stock options and sale of a combined 18,569 shares of common stock across August 25 and August 26, 2026, both executed under a Rule 10b5-1 plan adopted January 30, 2026, leaving him with 306,444 directly held shares.



Please wait processing your request...